187 related articles for article (PubMed ID: 31432406)
1. CSF Sample Preparation for Data-Independent Acquisition.
Barkovits K; Tönges L; Marcus K
Methods Mol Biol; 2019; 2044():61-67. PubMed ID: 31432406
[TBL] [Abstract][Full Text] [Related]
2. A Versatile Workflow for Cerebrospinal Fluid Proteomic Analysis with Mass Spectrometry: A Matter of Choice between Deep Coverage and Sample Throughput.
Macron C; Núñez Galindo A; Cominetti O; Dayon L
Methods Mol Biol; 2019; 2044():129-154. PubMed ID: 31432411
[TBL] [Abstract][Full Text] [Related]
3. Characterization of Cerebrospinal Fluid via Data-Independent Acquisition Mass Spectrometry.
Barkovits K; Linden A; Galozzi S; Schilde L; Pacharra S; Mollenhauer B; Stoepel N; Steinbach S; May C; Uszkoreit J; Eisenacher M; Marcus K
J Proteome Res; 2018 Oct; 17(10):3418-3430. PubMed ID: 30207155
[TBL] [Abstract][Full Text] [Related]
4. SWATH Mass Spectrometry Applied to Cerebrospinal Fluid Differential Proteomics: Establishment of a Sample-Specific Method.
Anjo SI; Santa C; Manadas B
Methods Mol Biol; 2019; 2044():169-189. PubMed ID: 31432413
[TBL] [Abstract][Full Text] [Related]
5. Deployment of Label-Free Quantitative Olfactory Proteomics to Detect Cerebrospinal Fluid Biomarker Candidates in Synucleinopathies.
Lachén-Montes M; González-Morales A; Fernández-Irigoyen J; Santamaría E
Methods Mol Biol; 2019; 2044():273-289. PubMed ID: 31432419
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the Sensitivity and Reproducibility of Targeted Proteomic Analysis Using Data-Independent Acquisition for Serum and Cerebrospinal Fluid Proteins.
Cho KC; Oh S; Wang Y; Rosenthal LS; Na CH; Zhang H
J Proteome Res; 2021 Sep; 20(9):4284-4291. PubMed ID: 34384221
[TBL] [Abstract][Full Text] [Related]
7. Top-Down Proteomics Applied to Human Cerebrospinal Fluid.
Gay M; Sánchez-Jiménez E; Villarreal L; Vilanova M; Huguet R; Arauz-Garofalo G; Díaz-Lobo M; López-Ferrer D; Vilaseca M
Methods Mol Biol; 2019; 2044():193-219. PubMed ID: 31432414
[TBL] [Abstract][Full Text] [Related]
8. Quantitative label-free proteomics for discovery of biomarkers in cerebrospinal fluid: assessment of technical and inter-individual variation.
Perrin RJ; Payton JE; Malone JP; Gilmore P; Davis AE; Xiong C; Fagan AM; Townsend RR; Holtzman DM
PLoS One; 2013; 8(5):e64314. PubMed ID: 23700471
[TBL] [Abstract][Full Text] [Related]
9. Combined tissue and fluid proteomics with Tandem Mass Tags to identify low-abundance protein biomarkers of disease in peripheral body fluid: An Alzheimer's Disease case study.
Russell CL; Heslegrave A; Mitra V; Zetterberg H; Pocock JM; Ward MA; Pike I
Rapid Commun Mass Spectrom; 2017 Jan; 31(2):153-159. PubMed ID: 27813239
[TBL] [Abstract][Full Text] [Related]
10. Label-Free LC-MS/MS Proteomic Analysis of Cerebrospinal Fluid Identifies Protein/Pathway Alterations and Candidate Biomarkers for Amyotrophic Lateral Sclerosis.
Collins MA; An J; Hood BL; Conrads TP; Bowser RP
J Proteome Res; 2015 Nov; 14(11):4486-501. PubMed ID: 26401960
[TBL] [Abstract][Full Text] [Related]
11. Robust two-dimensional separation of intact proteins for bottom-up tandem mass spectrometry of the human CSF proteome.
Bora A; Anderson C; Bachani M; Nath A; Cotter RJ
J Proteome Res; 2012 Jun; 11(6):3143-9. PubMed ID: 22537003
[TBL] [Abstract][Full Text] [Related]
12. Sample Fractionation Techniques for CSF Peptide Spectral Library Generation.
Pacharra S; Marcus K; May C
Methods Mol Biol; 2019; 2044():69-77. PubMed ID: 31432407
[TBL] [Abstract][Full Text] [Related]
13. High throughput and accurate serum proteome profiling by integrated sample preparation technology and single-run data independent mass spectrometry analysis.
Lin L; Zheng J; Yu Q; Chen W; Xing J; Chen C; Tian R
J Proteomics; 2018 Mar; 174():9-16. PubMed ID: 29278786
[TBL] [Abstract][Full Text] [Related]
14. Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset.
Chiasserini D; van Weering JR; Piersma SR; Pham TV; Malekzadeh A; Teunissen CE; de Wit H; Jiménez CR
J Proteomics; 2014 Jun; 106():191-204. PubMed ID: 24769233
[TBL] [Abstract][Full Text] [Related]
15. Application of an Aptamer-Based Proteomics Assay (SOMAscan™) in Rat Cerebrospinal Fluid.
Simats A; Ramiro L; Montaner J; García-Berrocoso T
Methods Mol Biol; 2019; 2044():221-231. PubMed ID: 31432415
[TBL] [Abstract][Full Text] [Related]
16. Mass Defect-Based DiLeu Tagging for Multiplexed Data-Independent Acquisition.
Zhong X; Frost DC; Yu Q; Li M; Gu TJ; Li L
Anal Chem; 2020 Aug; 92(16):11119-11126. PubMed ID: 32649829
[TBL] [Abstract][Full Text] [Related]
17. Determination of Cerebrospinal Fluid Proteome Variations by Isobaric Labeling Coupled with Strong Cation-Exchange Chromatography and Tandem Mass Spectrometry.
Lachén-Montes M; González-Morales A; Fernández-Irigoyen J; Santamaría E
Methods Mol Biol; 2019; 2044():155-168. PubMed ID: 31432412
[TBL] [Abstract][Full Text] [Related]
18. Deep Dive on the Proteome of Human Cerebrospinal Fluid: A Valuable Data Resource for Biomarker Discovery and Missing Protein Identification.
Macron C; Lane L; Núñez Galindo A; Dayon L
J Proteome Res; 2018 Dec; 17(12):4113-4126. PubMed ID: 30124047
[TBL] [Abstract][Full Text] [Related]
19. Peptidomic Workflow Applied to Cerebrospinal Fluid Analysis.
Ziganshin RH; Kovalchuk SI; Azarkin IV
Methods Mol Biol; 2019; 2044():111-118. PubMed ID: 31432409
[TBL] [Abstract][Full Text] [Related]
20. A Proteomic Analysis of Individual and Gender Variations in Normal Human Urine and Cerebrospinal Fluid Using iTRAQ Quantification.
Guo Z; Zhang Y; Zou L; Wang D; Shao C; Wang Y; Sun W; Zhang L
PLoS One; 2015; 10(7):e0133270. PubMed ID: 26222143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
